Similar articles

• Differentiation of genetic versus epigenetic mechanisms of toxicity and its application to risk assessment.

  Stott WT, Watanabe PG. Stott WT, et al. Drug Metab Rev. 1982;13(5):853-73. doi: 10.3109/03602538208991365. Drug Metab Rev. 1982. PMID: 6754312 Review. No abstract available.
• Cancer dose-response models.

  Sielken RL, Smith LA. Sielken RL, et al. Dev Toxicol Environ Sci. 1983;11:173-80. Dev Toxicol Environ Sci. 1983. PMID: 6677454 No abstract available.
• Dose response problems in carcinogenesis.

  Crump KS. Crump KS. Biometrics. 1979 Mar;35(1):157-67. Biometrics. 1979. PMID: 497333
• [Mathematical dose-effect models in the study of carcinogenesis].

  Parfenov IuD. Parfenov IuD. Vopr Onkol. 1986;32(1):9-22. Vopr Onkol. 1986. PMID: 3511610 Review. Russian. No abstract available.
• Assessment of the carcinogenicity and mutagenicity of chemicals. Report of a WHO Scientific Group.

  [No authors listed] [No authors listed] World Health Organ Tech Rep Ser. 1974;546(0):1-19. World Health Organ Tech Rep Ser. 1974. PMID: 4214379 No abstract available.